Jim Frates
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jim Frates
Jim Frates is recorded as CFO at Amylyx Pharmaceuticals, Inc. (AMLX) and CFO at Alkermes plc. (ALKS). Jim Frates has spoken on 4 earnings calls across 1 company, most recently for Amylyx Pharmaceuticals, Inc. on March 3, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Amylyx Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Camille Bedrosian Board Member
- George Mclean Milne Jr Board Member
- Gina M. Mazzariello Board Member
- James Frates Board Member
- Joshua Cohen Board Member
- Justin Klee Board Member
- Paul Fonteyne Board Member
Leadership on record at Alkermes plc.
Other people whose current roles at this company are on record from its filings.
- Blair C. Jackson CEO, CFO, COO
- Mr. Richard F. Pops CEO
- Iain M. Brown CFO, Chief Accounting Officer
- Blair Jackson COO
- James A. Robinson COO
- Samuel J. Parisi Chief Accounting Officer
- Andy Wilson Board Member
- Anne C. Whitaker Board Member
- Brian McKeon Board Member
- Brian P. McKeon Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.